Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (251-260 of 377) with videos related to

Pageof 38
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2017
Establishing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate CancerWolfgang P Fendler, Andreea D Stuparu, Susan Evans-Axelsson, et al.
European Journal of Radiology|November 15, 2011
Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correctionMatthias Eiber, Michael Souvatzoglou, Anja Pickhard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2015
Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyMatthias Eiber, Tobias Maurer, Michael Souvatzoglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2016
Prospective evaluation of [<sup>11</sup>C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancerSarah M Schwarzenböck, Matthias Eiber, Günther Kundt, et al.
World Journal of Urology|August 12, 2024
Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patientsRoman Mayr, Simon Udo Engelmann, Yushan Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2024
Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide TherapyLisa Steinhelfer, Friederike Jungmann, Lukas Endrös, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2023
Renal and Multiorgan Safety of <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry SubstudyKen Herrmann, Kambiz Rahbar, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 2, 2024
Safety and Efficacy of Extended Therapy with [<sup>177</sup>Lu]Lu-PSMA: A German Multicenter StudyRobert Seifert, Tugce Telli, Constantin Lapa, et al.
Scientific Reports|April 16, 2015
Non-invasive differentiation of kidney stone types using X-ray dark-field radiographyKai Scherer, Eva Braig, Konstantin Willer, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 29, 2024
Impact of a dedicated cardiac protocol on diagnosis of infective endocarditis in patients undergoing [<sup>18</sup>F]-FDG-thoracic digital-PET/CT - Effects of expertise levelSusan Notohamiprodjo, Klemens Scheidhauer, Matthias Eiber, et al.
Pageof 38

Showing results (251-260 of 377) with videos related to

Sort By:
Pageof 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2017
Establishing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate CancerWolfgang P Fendler, Andreea D Stuparu, Susan Evans-Axelsson, et al.
European Journal of Radiology|November 15, 2011
Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correctionMatthias Eiber, Michael Souvatzoglou, Anja Pickhard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2015
Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyMatthias Eiber, Tobias Maurer, Michael Souvatzoglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2016
Prospective evaluation of [<sup>11</sup>C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancerSarah M Schwarzenböck, Matthias Eiber, Günther Kundt, et al.
World Journal of Urology|August 12, 2024
Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patientsRoman Mayr, Simon Udo Engelmann, Yushan Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2024
Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide TherapyLisa Steinhelfer, Friederike Jungmann, Lukas Endrös, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2023
Renal and Multiorgan Safety of <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry SubstudyKen Herrmann, Kambiz Rahbar, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 2, 2024
Safety and Efficacy of Extended Therapy with [<sup>177</sup>Lu]Lu-PSMA: A German Multicenter StudyRobert Seifert, Tugce Telli, Constantin Lapa, et al.
Scientific Reports|April 16, 2015
Non-invasive differentiation of kidney stone types using X-ray dark-field radiographyKai Scherer, Eva Braig, Konstantin Willer, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 29, 2024
Impact of a dedicated cardiac protocol on diagnosis of infective endocarditis in patients undergoing [<sup>18</sup>F]-FDG-thoracic digital-PET/CT - Effects of expertise levelSusan Notohamiprodjo, Klemens Scheidhauer, Matthias Eiber, et al.
Pageof 38